We, therefore, initiated this study to obtain an indepth understanding of the effect of MyD88 inhibition by ST2825 on systemic inflammation generated by the peripheral blood mononuclear cells (PBMC) from RA patients. Here, MYD88 is linked to rheumatoid arthritis.